&format=webp&quality=medium)
Noida-headquartered electronics manufacturing service (EMS) provider Dixon Technologies staged a strong financial performance for the quarter ended March 31, with better-than-expected headline numbers and a largely steady margin.
After market hours on Tuesday, the EMS firm reported a consolidated net profit of Rs 256.4 crore for the January-March period, marking a fall of 36 per cent on a year-on-year basis. Its revenue grew 2.1 per cent on a year-on-year basis to Rs 10,510.5 crore for the March quarter, according to a regulatory filing.
Both headline numbers exceeded analysts' expectations.
According to Zee Business research, Dixon Technologies was estimated to register a March-quarter net profit of Rs 164 crore with Rs 10,126 crore in top line.
For the final quarter of FY25, the company's net profit had stood at Rs 401 crore, including an exeptional gain of Rs 250 crore on account of a share subscription and purchase agreement with Aditya Infotech.
Operational performance
Its fourth-quarter EBITDA declined 7.8 per cent to Rs 408 crore, with a margin of 3.9 per cent.
The operational numbers too were better than Street estimates.
According to Zee Business research, the EMS company was estimated to register a quarterly EBITDA of Rs 377 crore. Its fourth-quarter margin was estimated at 3.7 per cent.
FY26 earnings
For the year ended March 31, Dixon reported a 31.3 per cent jump in net profit to Rs 1,438.6 crore.
Its FY26 revenue stood at Rs 48,872.8 crore, up 25.8 per cent on a year-on-year basis.
The company declared a dividend of Rs 10 per equity share -- a 500 per cent payout given the face value of Rs 2 per equity share.
The payout is subject to shareholders' approval at the company's next AGM.
Brokerages maintained mixed views after the earnings announcement, with their latest targets ranging from Rs 9,790 to Rs 15,000 versus its current level of Rs 10,770.4.
| Brokerage | Rating | Target Price (Rs) | Upside/downside vs previous close |
| JP Morgan | Overweight | 12,700 | 17.9% |
| Jefferies | Hold | 10,280 | -4.6% |
| CLSA | Hold | 10,400 | -3.4% |
| Goldman Sachs | Sell | 9,790 | -9.1% |
| UBS | Buy | 13,700 | 27.2% |
| HSBC | Hold | 12,000 | 11.4% |
| Macquarie | Outperform | 15,000 | 39.3% |